Literature DB >> 17034007

Follow-up mapping supports the evidence for linkage in the candidate region at 9q22 in the NIMH Alzheimer's disease Genetics Initiative cohort.

Rodney T Perry1, Howard Wiener, Lindy E Harrell, Deborah Blacker, Rudolph E Tanzi, Lars Bertram, Susan S Bassett, Rodney C P Go.   

Abstract

Other than the APOE peak at 19q13, the 9q22 region was identified in our original genomic scan as the candidate region with the highest multipoint lod score (MLS) in the subset of late onset Alzheimer's Disease (AD) families (MLS = 2.9 at 101 cM) from the NIMH Genetics Initiative sample. We have now genotyped an additional 12 short tandem repeats (STR) in this region. Multipoint analysis shows the region remains significant with an increase in the peak MLS from 2.9 to 3.8 at 95 cM near marker D9S1815, and the 1 LOD interval narrows from 21.5 to 11 cM. HLOD scores also provide evidence for significant linkage (4.5 with an alpha = 31%) with a further narrowing of the region to 6.6 cM (92.2-98.8 cM). Single nucleotide polymorphisms (SNPs) in the Ubiquilin1 gene (UBQLN1), located at 83.3 cM, have been reported to be significantly associated to AD, accounting for a substantial portion of the original linkage signal [Bertram et al., 2005]. Our analyses of the higher resolution genotype data generated here provide further support for the existence of a least one additional locus on chromosome 9q22. In an effort to pinpoint this putative AD susceptibility gene, we have begun to analyze SNPs in other candidate genes in and around this narrowed region to test for additional associations to AD. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17034007     DOI: 10.1002/ajmg.b.30433

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  6 in total

1.  Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data.

Authors:  Richard Sherva; Clinton T Baldwin; Rivka Inzelberg; Badri Vardarajan; L Adrienne Cupples; Kathryn Lunetta; Abdalla Bowirrat; Adam Naj; Margaret Pericak-Vance; Robert P Friedland; Lindsay A Farrer
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 2.  The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.

Authors:  X Du; R A Hill
Journal:  J Mol Neurosci       Date:  2016-08-15       Impact factor: 3.444

3.  Ubiquilin overexpression reduces GFP-polyalanine-induced protein aggregates and toxicity.

Authors:  Hongmin Wang; Mervyn J Monteiro
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

4.  Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2.

Authors:  Diana L Ford; Mervyn J Monteiro
Journal:  Biochemistry       Date:  2007-07-06       Impact factor: 3.162

5.  Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.

Authors:  Joseph H Lee; Rong Cheng; Neill Graff-Radford; Tatiana Foroud; Richard Mayeux
Journal:  Arch Neurol       Date:  2008-11

6.  TrkB Isoforms Differentially Affect AICD Production through Their Intracellular Functional Domains.

Authors:  Sara Ansaloni; Brian P Leung; Neeraj P Sebastian; Rohini Samudralwar; Mariana Gadaleta; Aleister J Saunders
Journal:  Int J Alzheimers Dis       Date:  2011-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.